“In commissioning services for a small biotech, I was drawn to the wide-ranging experiences within ProTherax, combined with their willingness to engage in a fixed cost program. This allowed us to have our study reports written up, our vigilance obligations maintained and our EU and US regulatory activities completed all under one contract; without fear of budget over-runs. In each area the work was to the highest quality.”
Chief Medical Officer – UK Biotech

“I was looking for a consultancy that could help us map out a development pathway for a new venture; ProTherax not only provided us with a detailed review and fully supported our efforts to seek regulatory advice, but additionally provided us with a detailed clinical protocol, allowing us to cost a project to proof of concept. Throughout the project I found them to be diligent, highly responsive, proactive, communicative and extremely good value.”
Portfolio Investment Manager - Venture Capital Company

“With his extensive knowledge and experience in pharmaceutical regulatory affairs David has been invaluable in helping advance our licensed product portfolio to current regulatory expectations. He has also identified and provided a high standard of essential training to our regulatory team and is someone who we will continue to work with in the future.”

Account Manager – Multi-national Pharmaceutical Company

"Work carried out by ProTherax, in connection with Clinical Evaluations of medical device products was of a very satisfactory standard, in full compliance with the Medical Device Directive requirements...the work was consistently provided in timely fashion. The evaluations in question covered quite a broad range of our product portfolio, including CE marked biocides, various procedure packs and plain & x-ray detectable gauzes & swabs. The classifications of such products ranged from Class I, non sterile to Class IIb, sterile."

Quality Manager - Medical Device Manufacturer